Why the study?
Does FFR-guided PCI improve outcomes in patients with stable coronary artery disease compared to medical therapy alone?
Does FFR-guided PCI improve outcomes in patients with stable coronary artery disease compared to medical therapy alone?
In patients with stable coronary artery disease, FFR-guided PCI improves outcomes compared to medical therapy alone, whereas patients without ischemia have favorable outcomes with medical therapy alone.
Answers are grounded in this paper and cite their sources.
Supports FFR-guided PCI in stable CAD with ischemia; confirms benefit of physiology-driven revascularization over medical therapy.
In patients with stable coronary artery disease, FFR-guided PCI, as compared with medical therapy alone, improved the outcome. Patients without ischemia had a favorable outcome with medical therapy alone. (Funded by St. Jude Medical; FAME 2 ClinicalTrials.gov number, NCT01132495.).
No takes yet. Share an insight, caveat, or question.
Bruyne et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: